1,3-oxathiolanes useful in the treatment of hepatitis
US5486520A · kind A · utility
48Cited by
5References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 1993 |
| Grant date | Jan 23, 1996 |
| Priority date | — |
| Expiry date | Dec 10, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of nucleoside analogues in the treatment of viral infections. More specifically it is concerned with the use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis, in particular hepatitis B.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.